The researchers isolated small extracellular vesicles, or sEVs, and cellular nanovesicles, or NVs, from MDA231 and 8988t cells. The two classes had comparable particle sizes and surface charges. They labeled the particles either with PbS quantum dots or with the membrane dye PKH26, allowing the investigators to compare their behavior under visible or near-infrared fluorescence imaging. The experimental comparison focused primarily on vesicles from different cellular origins: MDA231-derived particles showed greater uptake by MDA231 cells in vitro than particles derived from 8988t cells. The measured CD9 tetraspanin content also differed, with NVs showing greater CD9 inheritance than sEVs after normalization to the total protein input from the same parental cell. The reported results did not establish which molecular or cellular features accounted for the differences in uptake or tumor accumulation.

In the mouse experiments, fluorescence imaging showed broadly similar circulation profiles for MDA231- and 8988t-derived sEVs and NVs, with half-lives of about four to five hours. Tumor accumulation, however, differed according to the relationship between the vesicle source and the tumor. MDA231-derived sEVs and NVs accumulated more in mice bearing MDA231 tumors than did the corresponding vesicles derived from 8988t cells, indicating a preferential accumulation in the homologous tumor in this model. The choice of fluorescent label also mattered for imaging performance: PbS quantum-dot labeling produced stronger and more stable fluorescence signals than PKH26. These observations are distinct from the biological comparison, because they describe the stability of the imaging signal rather than an additional effect of the vesicles on tumors.

The findings support further investigation of tumor-derived sEVs and NVs as possible targeted delivery platforms for cancer therapy, but they do not demonstrate therapeutic benefit in humans. The work involved particles from two human cancer cell lines, uptake testing in cultured cells and biodistribution studies in MDA231 cell-xenografted mice. It measured physicochemical characteristics, cellular uptake, pharmacokinetics, tumor accumulation and distribution rather than improved treatment outcomes, lower toxicity or effective therapeutic dosing. The results therefore support a measurable origin-associated tumor preference under the tested laboratory conditions, while the extent to which that preference applies across other tumor types and its relevance to patients remain unresolved.

Subject of Research: Comparative imaging of tumor-derived small extracellular vesicles and cellular nanovesicles in breast and pancreatic cancer models

Article Title: Quo vadis? – Visualizing the tropism of tumor-derived cellular nanovesicles

Article References: Guo, Y., Zhou, K., Chen, Y., Zhang, J., & Tao, Z. (2026). Quo vadis? – Visualizing the tropism of tumor-derived cellular nanovesicles. BMC Cancer. https://doi.org/10.1186/s12885-026-16875-6

Image Credits: AI Generated

DOI: 10.1186/s12885-026-16875-6

Keywords: extracellular vesicles, cellular nanovesicles, tumor tropism, cancer cell lines, mouse xenografts, biodistribution, breast cancer, pancreatic cancer, quantum-dot imaging, drug delivery, vadis, Visualizing

The trial, published in BMC Medical Education, was designed to examine holographic visualization during preclinical training in prosthodontics, where students must develop spatial understanding and psychomotor precision. Sixty undergraduates were randomly assigned, 30 to each condition, to receive either conventional two-dimensional photographic visualization or holographic three-dimensional visualization. After a standardized calibration session and a baseline veneer preparation, participants completed a second preparation following exposure to their assigned visualization modality. The researchers used this before-and-after structure to measure change within each group, while also adjusting the between-group comparison for baseline performance. The trial was prospectively registered in the German Clinical Trials Register on 22 June 2026 under the identifier DRKS00040713.

Preparation quality was evaluated independently by two blinded evaluators using a predefined scoring rubric. Within-group changes were analyzed with Wilcoxon signed-rank tests, and differences between groups were assessed with analysis of covariance adjusted for baseline performance. Student-reported educational outcomes were compared using Mann–Whitney U tests with false discovery rate correction. The investigators reported significant improvements in preparation quality from baseline to post-intervention in both groups, with p values below 0.001. That similar pattern of improvement means the principal result was not evidence that holography outperformed photographs; the study did not show a significant preparation-quality advantage for the three-dimensional condition.

Student-reported outcomes were broadly comparable between the two groups. Spatial understanding showed the largest observed between-group effect in favor of holographic visualization, but the difference was not significant after the multiple-comparison correction. Holographic visualization was nevertheless highly accepted: 70% of students supported its future integration into dental education. The findings separate that acceptance from the measured performance result. The technology was popular with students, and the largest observed student-reported difference concerned spatial understanding, but the trial did not establish a statistically significant advantage for either overall student-reported outcomes or immediate veneer-preparation quality.

Overall, the results position holographic visualization as a possible adjunct for teaching complex three-dimensional concepts in preclinical prosthodontic education, rather than as a demonstrated replacement for conventional visual methods or a clearly superior route to better preparation scores. The evidence comes from a single randomized trial of 60 dental undergraduates, a specific veneer-preparation exercise and short-term educational outcomes in simulated training; it does not establish effects in clinical patient care, long-term retention or later professional practice. The authors concluded that holographic visualization may primarily support spatial understanding and may be valuable as an adjunct in preclinical training, but the measured preparation-quality difference between holographic and conventional visualization was not statistically significant.

Subject of Research: Randomized trial of holographic versus two-dimensional visualization in preclinical dental veneer-preparation training

Article Title: Visualizing the future: impact of holographic visualization on teaching minimally invasive veneer preparation: a randomized controlled trial

Article References: Janson, M., Lederer, M. L., Dalhoff, C. M., Barbe, A. G., Liebermann, A., & Schoppmeier, C. M. (2026). Visualizing the future: impact of holographic visualization on teaching minimally invasive veneer preparation: a randomized controlled trial. BMC Medical Education, 26(1), Article 1447. https://doi.org/10.1186/s12909-026-10324-5

Image Credits: AI Generated

DOI: 10.1186/s12909-026-10324-5

Keywords: randomized controlled trial, dental education, holographic visualization, minimally invasive veneer preparation, spatial understanding, undergraduate dentistry, preclinical training, prosthodontics, three-dimensional visualization, Visualizing, future, impact